Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies

Peer Review reports

Original Submission
3 Sep 2015	Submitted	Original manuscript
31 May 2015	Reviewed	Reviewer Report - Zachary T. Bloomgarden
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
8 Jan 2016	Editorially accepted
15 Jan 2016	Article published	10.1186/s12872-016-0187-5

Back to article page